The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy-Reference-Cited by-同舟云学术

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

Published:2011-08-15 Issue:6 Volume:3 Page:257-267
ISSN:1758-8340
Container-title:Therapeutic Advances in Medical Oncology
language:en
Short-container-title:Ther Adv Med Oncol

Author:

Javle M.¹,Curtin N. J.²

Affiliation:

1. Associate Professor, UT-MD Anderson Cancer Center, Houston, TX, USA

2. Professor of Experimental Cancer Therapeutics, Northern Institute for Cancer Research, Medical School, University of Newcastle upon Tyne, NE2 4HH, UK

Publisher

SAGE Publications

Subject

Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1758834011417039

Reference63 articles.

1. Poly(ADP-ribose)–Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1

2. DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer

3. Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?

4. Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase

5. A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional regulation mechanism of PARP1 and its application in disease treatment;Epigenetics & Chromatin;2024-08-08

2. Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status;Breast Cancer;2024-06-13

3. Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study;npj Breast Cancer;2023-10-06

4. Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast;Oncology and Therapy;2023-09-14

5. MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer;Cells;2023-07-25